Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.
作者信息
Boyd Kerry, Woodbury-Smith Marc, Szatmari Peter
机构信息
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont.
出版信息
J Psychiatry Neurosci. 2011 Jul;36(4):E35-6. doi: 10.1503/jpn.110040.
Abstract
摘要
相似文献
1
Managing anxiety and depressive symptoms in adults with autism-spectrum disorders.管理患有自闭症谱系障碍的成年人的焦虑和抑郁症状。
J Psychiatry Neurosci. 2011 Jul;36(4):E35-6. doi: 10.1503/jpn.110040.
2
Anxiety with depression: a treatment need.焦虑伴抑郁：一种治疗需求。
Eur Neuropsychopharmacol. 1999 Jul;9 Suppl 3:S87-92. doi: 10.1016/s0924-977x(99)00027-9.
3
Serotonin 2A receptor gene (HTR2A) regulatory variants: possible association with severity of depression symptoms in children with autism spectrum disorder.血清素2A受体基因（HTR2A）调控变异：与自闭症谱系障碍儿童抑郁症状严重程度的可能关联。
Cogn Behav Neurol. 2014 Jun;27(2):107-16. doi: 10.1097/WNN.0000000000000028.
4
5
Pharmacogenetics of treating pediatric anxiety and depression.治疗儿童焦虑症和抑郁症的药物遗传学
Pharmacogenomics. 2019 Aug;20(12):867-870. doi: 10.2217/pgs-2019-0088.
6
[Serotonin neurotrasmission and treatment options for depression].[血清素神经传递与抑郁症的治疗选择]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11):174-177. doi: 10.17116/jnevro2017117111174-177.
7
Adjuvant trazodone in the treatment of alcoholism: an open study.辅助曲唑酮治疗酒精中毒：一项开放性研究。
Alcohol Alcohol. 1998 Jul-Aug;33(4):362-5. doi: 10.1093/oxfordjournals.alcalc.a008405.
8
[Guidelines for care of young people with anxiety and depression should be revised].
Lakartidningen. 2010;107(45):2823-4; discussion 2825.
9
Commentary: considerations on the pharmacological treatment of compulsions and stereotypies with serotonin reuptake inhibitors in pervasive developmental disorders.评论：关于在广泛性发育障碍中使用5-羟色胺再摄取抑制剂治疗强迫行为和刻板动作的药理学思考
J Autism Dev Disord. 2000 Oct;30(5):437-8. doi: 10.1023/a:1005503607728.
10
The use of selective serotonin reuptake inhibitors in autism and related disorders.选择性5-羟色胺再摄取抑制剂在自闭症及相关疾病中的应用。
J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):181-6. doi: 10.1089/cap.2006.16.181.
引用本文的文献
1
Polyphenols: Natural Food-Grade Biomolecules for the Treatment of Nervous System Diseases from a Multi-Target Perspective.多酚：从多靶点角度看用于治疗神经系统疾病的天然食品级生物分子
Pharmaceuticals (Basel). 2024 Jun 13;17(6):775. doi: 10.3390/ph17060775.
2
Measuring Social Camouflaging in Individuals with High Functioning Autism: A Literature Review.高功能自闭症个体的社交伪装测量：文献综述
Brain Sci. 2023 Mar 10;13(3):469. doi: 10.3390/brainsci13030469.
3
Stronger Associations Between Sleep and Mental Health in Adults with Autism: A UK Biobank Study.自闭症成人的睡眠与心理健康之间关联更强：英国生物银行研究。
J Autism Dev Disord. 2023 Apr;53(4):1543-1559. doi: 10.1007/s10803-021-05382-1. Epub 2021 Dec 3.
4
Diagnostic Challenges of High-Functioning Autism Spectrum Disorder in Females.女性高功能自闭症谱系障碍的诊断挑战
Cureus. 2021 Jan 30;13(1):e13006. doi: 10.7759/cureus.13006.
5
Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior.Arid1b单倍体不足会破坏皮质中间神经元的发育和小鼠行为。
Nat Neurosci. 2017 Dec;20(12):1694-1707. doi: 10.1038/s41593-017-0013-0. Epub 2017 Nov 6.
6
The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.啮齿动物强迫游泳试验测量的是应激应对策略，而非类似抑郁的行为。
ACS Chem Neurosci. 2017 May 17;8(5):955-960. doi: 10.1021/acschemneuro.7b00042. Epub 2017 Mar 22.
7
Quantifying and exploring camouflaging in men and women with autism.量化并探究自闭症男性和女性的伪装行为。
Autism. 2017 Aug;21(6):690-702. doi: 10.1177/1362361316671012. Epub 2016 Nov 29.
8
An investigation of the 'female camouflage effect' in autism using a computerized ADOS-2 and a test of sex/gender differences.一项使用计算机化的《自闭症诊断观察量表第二版》（ADOS-2）对自闭症中“女性伪装效应”及性别差异进行的研究。
Mol Autism. 2016 Jan 21;7:10. doi: 10.1186/s13229-016-0073-0. eCollection 2016.
9
Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan.自闭症谱系障碍患者全生命周期中抑郁症的诊断与治疗挑战
Dialogues Clin Neurosci. 2015 Jun;17(2):219-27. doi: 10.31887/DCNS.2015.17.2/tchandrasekhar.
10
Educational Experiences and Needs of Higher Education Students with Autism Spectrum Disorder.患有自闭症谱系障碍的高等教育学生的教育经历与需求
J Autism Dev Disord. 2016 Jan;46(1):31-41. doi: 10.1007/s10803-015-2535-1.
本文引用的文献
1
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).用于自闭症谱系障碍（ASD）的选择性5-羟色胺再摄取抑制剂（SSRI）
Cochrane Database Syst Rev. 2010 Aug 4(8):CD004677. doi: 10.1002/14651858.CD004677.pub2.
2
International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities.国际成人智力残疾患者问题行为管理精神药物处方指南。
World Psychiatry. 2009 Oct;8(3):181-6. doi: 10.1002/j.2051-5545.2009.tb00248.x.
3
Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.2007-2008 年全国自闭症谱系障碍儿童注册研究中的精神药物使用情况。
J Autism Dev Disord. 2010 Mar;40(3):342-51. doi: 10.1007/s10803-009-0878-1.
4
Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.自闭症中选择性5-羟色胺再摄取抑制剂：疗效与耐受性综述
J Clin Psychiatry. 2006 Mar;67(3):407-14. doi: 10.4088/jcp.v67n0311.
5
Safety issues with drug therapies for autism spectrum disorders.自闭症谱系障碍药物治疗的安全性问题。
J Clin Psychiatry. 2005;66 Suppl 10:32-7.
6
An update on pharmacologic treatments for autism spectrum disorders.自闭症谱系障碍药物治疗的最新进展。
Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):161-75. doi: 10.1016/j.chc.2005.08.005.
Zotero 插件